Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5553)	9/9/1998 8:38:00 PM
From: Alan Newman	Read Replies (1) \| Respond to of 7041

Some wild theories on the run-up today: could ZONA be buying back their own shares? could a hedge fund going out of business be covering their short position? I just think that if there really was some news, the volume would have been larger. Alan

To: Linda Kaplan who wrote (5553)	9/9/1998 8:38:00 PM
From: Claud B	Read Replies (2) \| Respond to of 7041

Linda, I don't think the run-up in the stock was related to an injectible form of the drug. I have no knowledge about that. What I DO think contributed is the probable acceptance of the NDA by the FDA within 3 or 4 days from now....which will trigger another $5 million payment by SGP. Don't know if you recall but perhaps 8 or 9 months ago, I posted here that it was impossible to argue with those on opposing sides. At that time, I said that the shorts would probably have an opposite view to the future accomplishments of Zonagen no matter what the news. As I recall, I said " NDA will be filed....shorts say yes, but it won't be accepted.....FDA will approve Vasomax....shorts respond with yes, but it won't sell." One of your posts earlier today falls right into that prediction. Claud